-
1
-
-
0028237958
-
Molecular biology and angiotensin receptors: Target for drug research?
-
Dzau VJ, Mukoyama P, Pratt RE. Molecular biology and angiotensin receptors: target for drug research? J Hypertens 1994; 12: S1-5.
-
(1994)
J. Hypertens.
, vol.12
-
-
Dzau, V.J.1
Mukoyama, P.2
Pratt, R.E.3
-
4
-
-
0027208070
-
Angiotensin II receptors and angiotensin II receptor antagonists
-
Timmermans PBMWM, Wong PC, Chiu AT, et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993; 45: 205-51.
-
(1993)
Pharmacol. Rev.
, vol.45
, pp. 205-251
-
-
Timmermans, P.B.M.W.M.1
Wong, P.C.2
Chiu, A.T.3
-
5
-
-
0029794052
-
Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy
-
Booz EW, Baker KM. Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy. Hypertension 1996; 28: 635-40.
-
(1996)
Hypertension
, vol.28
, pp. 635-640
-
-
Booz, E.W.1
Baker, K.M.2
-
6
-
-
0028840484
-
Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: A review
-
Dahlöf B. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review. J Hum Hypertens 1995; 9 Suppl: S37-44.
-
(1995)
J. Hum. Hypertens.
, vol.9
, Issue.SUPPL.
-
-
Dahlöf, B.1
-
7
-
-
0037160968
-
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
-
Dahlöf B, Devereux R, Kjeldsen S, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995-1003.
-
(2002)
Lancet
, vol.359
, pp. 995-1003
-
-
Dahlöf, B.1
Devereux, R.2
Kjeldsen, S.3
-
8
-
-
0034636121
-
Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan
-
Schiffrin EL, Park JB, Intengan HD, Touyz RM. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 2000; 101: 1653-9.
-
(2000)
Circulation
, vol.101
, pp. 1653-1659
-
-
Schiffrin, E.L.1
Park, J.B.2
Intengan, H.D.3
Touyz, R.M.4
-
9
-
-
0029065095
-
A randomized, placebo-controlled, double-blind, parallel study of various dosed of losartan potassium compared with enalapril maleate in patients with essential hypertension
-
Gradman AH, Arcuri KE, Goldberg AI, et al. A randomized, placebo-controlled, double-blind, parallel study of various dosed of losartan potassium compared with enalapril maleate in patients with essential hypertension. Hypertension 1995; 25: 1345-50.
-
(1995)
Hypertension
, vol.25
, pp. 1345-1350
-
-
Gradman, A.H.1
Arcuri, K.E.2
Goldberg, A.I.3
-
10
-
-
9044220224
-
Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension
-
Tikkanen I, Omvik P, Jensen HA. Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension. J Hypertens 1995; 13: 1343-51.
-
(1995)
J. Hypertens.
, vol.13
, pp. 1343-1351
-
-
Tikkanen, I.1
Omvik, P.2
Jensen, H.A.3
-
11
-
-
0030902115
-
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
-
Pitt B, Segal R, Martinez FA, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997; 349: 747-52.
-
(1997)
Lancet
, vol.349
, pp. 747-752
-
-
Pitt, B.1
Segal, R.2
Martinez, F.A.3
-
12
-
-
0035922441
-
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
-
Brenner BM, Cooper ME, De Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. New Engl J Med 2001; 345: 861-9.
-
(2001)
New Engl. J. Med.
, vol.345
, pp. 861-869
-
-
Brenner, B.M.1
Cooper, M.E.2
De Zeeuw, D.3
-
13
-
-
0034612118
-
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial - The Losartan Heart Failure Survival Study ELITE II
-
Pitt B, Poole-Wilson PA, Segal R, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II. Lancet 2000; 355: 1582-7.
-
(2000)
Lancet
, vol.355
, pp. 1582-1587
-
-
Pitt, B.1
Poole-Wilson, P.A.2
Segal, R.3
-
14
-
-
0035922447
-
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
-
Lewis E, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851-60.
-
(2001)
N. Engl. J. Med.
, vol.345
, pp. 851-860
-
-
Lewis, E.1
Hunsicker, L.G.2
Clarke, W.R.3
-
16
-
-
0142044774
-
The state of microcirculation in hypertensive disease (essential hypertension)
-
[in Russian]
-
Makolkin VI, Podsolkov VI, Pavlov VI, Bogdanova EA, Kamshilina LS, Samoilenko VV. The state of microcirculation in hypertensive disease (essential hypertension) [in Russian]. Kardiologia 2002; 7: 36-40.
-
(2002)
Kardiologia
, vol.7
, pp. 36-40
-
-
Makolkin, V.I.1
Podsolkov, V.I.2
Pavlov, V.I.3
Bogdanova, E.A.4
Kamshilina, L.S.5
Samoilenko, V.V.6
-
17
-
-
0025313654
-
Structural changes during microvascular rarefaction in chronic hypertension
-
Hansen Smith F, Greene AS, Covely JAS, et al. Structural changes during microvascular rarefaction in chronic hypertension. Hypertension 1990; 15: 922-8.
-
(1990)
Hypertension
, vol.15
, pp. 922-928
-
-
Hansen Smith, F.1
Greene, A.S.2
Covely, J.A.S.3
-
18
-
-
0032959098
-
Improvement in capillarity of the left ventricular wall of stroke-prone spontaneously hypertensive rats following angiotensin II receptor blockade
-
Xie Z, Gao M, Togashi H, et al. Improvement in capillarity of the left ventricular wall of stroke-prone spontaneously hypertensive rats following angiotensin II receptor blockade. Clin Exp Hypertens 1999; 21: 441-52.
-
(1999)
Clin. Exp. Hypertens.
, vol.21
, pp. 441-452
-
-
Xie, Z.1
Gao, M.2
Togashi, H.3
-
19
-
-
0031818850
-
Microvasculature in angiotensin II-dependent cardiac hypertrophy in the rat
-
Sabri A, Samuel J-L, Marrote F, et al. Microvasculature in angiotensin II-dependent cardiac hypertrophy in the rat. Hypertension 1998; 32: 371-5.
-
(1998)
Hypertension
, vol.32
, pp. 371-375
-
-
Sabri, A.1
Samuel, J.-L.2
Marrote, F.3
-
20
-
-
0030431329
-
Effects of prolonged blockade of the renin angiotensin system on striated muscle microcirculation of spontaneously hypertensive rats
-
Scheidegger KJ, Wood JM, van Essen H, Struijker-Boudier HA. Effects of prolonged blockade of the renin angiotensin system on striated muscle microcirculation of spontaneously hypertensive rats. J Pharmacol Exp Ther 1996; 278: 1276-81.
-
(1996)
J. Pharmacol. Exp. Ther.
, vol.278
, pp. 1276-1281
-
-
Scheidegger, K.J.1
Wood, J.M.2
van Essen, H.3
Struijker-Boudier, H.A.4
-
21
-
-
0142012915
-
The method of laser Doppler flowmetry in cardiology
-
[in Russian]. Moscow
-
Makolkin VI, Branko VV, Bogdanova EA The method of laser Doppler flowmetry in cardiology [in Russian]. Moscow, 1999.
-
(1999)
-
-
Makolkin, V.I.1
Branko, V.V.2
Bogdanova, E.A.3
-
22
-
-
0029958411
-
Laser Doppler perfusion imaging of skin blood flow using red and near-infrared sources
-
Abbot NC, Ferrell WR, Lockhart JC, Lowe JG. Laser Doppler perfusion imaging of skin blood flow using red and near-infrared sources. J Invest Dermatol 1990; 107: 882-6.
-
(1990)
J. Invest. Dermatol.
, vol.107
, pp. 882-886
-
-
Abbot, N.C.1
Ferrell, W.R.2
Lockhart, J.C.3
Lowe, J.G.4
-
23
-
-
0032646965
-
New techniques for clinical assessment of the peripheral microcirculation
-
Carpentier PH. New techniques for clinical assessment of the peripheral microcirculation. Drugs 1999; 58: 17-22.
-
(1999)
Drugs
, vol.58
, pp. 17-22
-
-
Carpentier, P.H.1
-
25
-
-
0032784461
-
Microcirculation in hypertension
-
Struijcer Boudier HAJ. Microcirculation in hypertension. Eur Heart J 1999; 1 Suppl: 32-7.
-
(1999)
Eur. Heart J.
, vol.1
, Issue.SUPPL.
, pp. 32-37
-
-
Struijcer Boudier, H.A.J.1
-
26
-
-
0142044775
-
Hypertension and microcirculation: An overview of experimental studies
-
Hypertension and microcirculation: an overview of experimental studies. Medocographia 1999; 21: 34-40.
-
(1999)
Medocographia
, vol.21
, pp. 34-40
-
-
-
27
-
-
0029969823
-
Effect of antihypertensive treatment on qualitative estimates of microalbuminuria
-
Agrawal B, Wolf K, Berger A, et al. Effect of antihypertensive treatment on qualitative estimates of microalbuminuria. J Hum Hypertens 1996; 10: 551-5.
-
(1996)
J. Hum. Hypertens.
, vol.10
, pp. 551-555
-
-
Agrawal, B.1
Wolf, K.2
Berger, A.3
-
28
-
-
0033035805
-
Effects of an angiotensin-converting enzyme inhibitor and a β-blocker on cerebral arterioles in rats
-
Chillon J-C, Baumbach GL. Effects of an angiotensin-converting enzyme inhibitor and a β-blocker on cerebral arterioles in rats. Hypertension 1999; 33: 856-61.
-
(1999)
Hypertension
, vol.33
, pp. 856-861
-
-
Chillon, J.-C.1
Baumbach, G.L.2
-
29
-
-
0030699961
-
Long-term ACE inhibition doubles lifespan of hypertensive rats
-
Linz W, Jessen T, Becker RH, et al. Long-term ACE inhibition doubles lifespan of hypertensive rats. Circulation 1997; 96: 3164-72.
-
(1997)
Circulation
, vol.96
, pp. 3164-3172
-
-
Linz, W.1
Jessen, T.2
Becker, R.H.3
-
30
-
-
0034109905
-
The effect of treatment with low dose ACE inhibitor and/or diuretic on coronary microvasculature in stroke-prone spontaneously hypertensive rats
-
Rakusan K, Cieutti N, Maurin A, et al. The effect of treatment with low dose ACE inhibitor and/or diuretic on coronary microvasculature in stroke-prone spontaneously hypertensive rats. Microvasc Res 2000; 59: 243-54.
-
(2000)
Microvasc. Res.
, vol.59
, pp. 243-254
-
-
Rakusan, K.1
Cieutti, N.2
Maurin, A.3
|